Translational Therapeutics

British Journal of Cancer (2005) 92, 503–512. doi:10.1038/sj.bjc.6602325 www.bjcancer.com
Published online 25 January 2005

Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process

C A Hart1, M Brown1, S Bagley2, M Sharrard3 and N W Clarke1,4,5

  1. 1PromPT Genito-Urinary Cancer Research, Cancer Research UK Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
  2. 2Advanced Imaging Facility, Cancer Research UK, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
  3. 3YCR Cancer Research Unit, Biology Department, The University of York, York YO10 5YW, UK
  4. 4Department of Urology, Salford Royal Hospital, Eccles Old Road, Salford, UK
  5. 5Christie Hospital NHS Trust, Wilmslow Road, Manchester, UK

Correspondence: Dr M Brown, E-mail: mbrown@picr.man.ac.uk

Received 14 October 2004; Revised 9 November 2004; Accepted 19 November 2004; Published online 25 January 2005.

Top

Abstract

Prostate cancer has a predilection to metastasise to the bone marrow stroma (BMS) by an as yet uncharacterised mechanism. We have defined a series of coculture models of invasion, which simulate the blood/BMS boundary and allow the elucidation of the signalling and mechanics of trans-endothelial migration within the complex bone marrow environment. Confocal microscopy shows that prostate epithelial cells bind specifically to bone marrow endothelial-to-endothelial cell junctions and initiate endothelial cell retraction. Trans-endothelial migration proceeds via an epithelial cell pseudopodial process, with complete epithelial migration occurring after 232plusminus43 min. Stromal-derived factor-1 (SDF-1)/CXCR4 signalling induced PC-3 to invade across a basement membrane although the level of invasion was 3.5-fold less than invasion towards BMS (P=0.0007) or bone marrow endothelial cells (P=0.004). Maximal SDF-1 signalling of invasion was completely inhibited by 10 muM of the SDF-1 inhibitor T140. However, 10 muM T140 only reduced invasion towards BMS and bone marrow endothelial cells by 59% (P=0.001) and 29% (P=0.011), respectively. This study highlights the need to examine the potential roles of signalling molecules and/or inhibitors, not just in single-cell models but in coculture models that mimic the complex environment of the bone marrow.

Keywords:

prostate, metastasis, CXCR4, bone marrow, endothelium